Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

08 October 2019: Original Paper  

Effects of a Structured Physical Activity Program on Serum Adipokines and Markers of Inflammation and Volume Overload in Kidney Transplant Recipients

Katarzyna Muras-Szwedziak ABCDEF 1, Anna Masajtis-Zagajewska AB 1, Ewa Pawłowicz C 2, Michał Nowicki ABCDEFG 1*

DOI: 10.12659/AOT.917047

Ann Transplant 2019; 24:569-575

0 Comments

Abstract

BACKGROUND: Kidney transplantation (KTx) reverses most abnormalities related to chronic kidney disease (CKD), but sedentary lifestyle persists in most kidney graft recipients. Physical inactivity has been associated with altered adipokine profile and inflammation in CKD. We postulated that increased physical activity achieved through an individually-tailored program can reverse these changes.

MATERIAL AND METHODS: We included 25 clinically stable KTx recipients at least 12 months after transplantation and with eGFR >30 mL/min and 15 age-matched non-dialysis patients with CKD stage 3. Body composition, pattern of daily physical activity, and serum concentrations of leptin, adiponectin, NT-proBNP, and hsCRP were assessed at baseline. All patients in both groups participated in a 12-week supervised exercise program with short cell phone text reminders. All measurements were repeated after 3 months.

RESULTS: Active energy expenditure increased significantly during the 3 months in both the KTx and CKD patients, compared with baseline by 47% (p<0.001) and 20% (p=0.01), respectively. Time spent daily on physical activity was also increased (129±83 vs. 194±142 and 81±56 vs. 124±57 min, respectively, p<0.001). Adipose tissue mass decreased significantly in the KTx group (from 40.8±11 to 38.5±10.3 kg, p=0.01). Serum leptin decreased significantly in both KTx and CKD patients (from 11.5±7.0 to 10.0±5.6, p=0.03 and from 14.1±8.3 to 12.2±6.1 ng/mL, p=0.01, respectively). Serum adiponectin increased only in the KTx group (from 1900±953 to 2015±1133 ng/L, p=0.004). Serum CRP decreased in both groups (from 15.1±5.2 to 14.0±5.6 mg/L, p=0.01 in the KTx group and from 16.5±3.9 to 15.4±4.3 mg/L in the CKD group p=0.05). NTpro-BNP was unchanged during the study.

CONCLUSIONS: Increased physical activity induces beneficial effects on adipokine profile and inflammation but does not seem to affect volume overload in kidney transplant recipients and CKD patients.

Keywords: adipokines, Kidney Transplantation, physical exertion, Renal Insufficiency, Chronic

Background

As in the general population, low physical activity level has been associated with increased risk of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD) [1] and in patients after kidney transplantation (KTx) [2].

Recent studies have shown that KTx recipients have on average 4 times higher risk of cardiovascular complications compared to the healthy population [3,4], but their risk is still much lower than in patients with chronic kidney disease on the waiting list for kidney transplantation [4].

A significant deterioration of general condition of patients with CKD, especially those with end-stage renal disease, causes a gradual decline in physical activity observed in this group of patients, and their sedentary lifestyle frequently persists after KTx [5]. Decreased physical activity not reduces quality of life and mental state, but is also associated with a number of detrimental consequences such as worsening of already existing inflammation and altered metabolic and heart conditions. These changes lead to a progressive injury to the cardiovascular system and other organs and systems, resulting in a number of complications [6].

Early introduction of modifications in daily lifestyle can significantly reduce the metabolic disturbances and extend the survival of patients and grafts [7]. Fat tissue has been found to be hormonally active, with the expression of several adipokines that regulate energy metabolism. Adiponectin and leptin are mostly expressed in adipocytes [8,9]. Adiponectin increases insulin sensitivity without influencing insulin levels [9] and has strong anti-atherosclerotic and anti-inflammatory effects. Leptin, in turn, reduces the synthesis of insulin, decreases lipogenesis, increases lipolysis in adipose tissue, and increases the activity of the sympathetic nervous system [10].

Wolf et al. found that increased leptin concentrations in obese patients can play a role in the pathogenesis of diabetic changes in the kidneys, mainly through the binding of leptin to its receptors expressed in the proximal kidney tubules [11]. This shows that the kidney is not only the location of leptin metabolism but is also its target organ [11].

C-reactive protein is a marker of inflammation and has also been used as a marker of cardiovascular risk [12]. There is a tight inverse relationship between serum CRP and physical activity [13], but this relation is ambiguous because physical activity can lead to higher CRP concentrations [14].

Brain natriuretic peptide (BNP) is a natriuretic hormone secreted by cardiomyocytes, and its concentration reflects the volume of load on the cardiovascular system. Its serum concentration has been recognized as an independent cardiovascular risk factor in patients with impaired kidney function [15].

Most of the recent studies related to physical activity in CKD and KTx patients have focused on the dialysis population, and only a few included patients after kidney transplantation and compared them to the patients with CKD without a history of kidney transplantation. One recent study, conducted in a group of 32 subjects, revealed that physical activity increased by 30% in the first year after transplantation. Despite the increase, the level of physical activity in these patients was still comparable to the population of elderly people without renal insufficiency [16].

Another study revealed that an increase in habitual activity levels in CKD patients led to reduced systemic inflammation. The patients with highest baseline concentration of serum inflammation markers had the greatest benefits from physical training [13].

The aim of the present study was to compare the effects of a structured physical activity program on the biomarkers of inflammation and volume overload in patients after renal transplantation and in subjects with stage 3 and 4 chronic kidney disease.

Material and Methods

STATISTICAL ANALYSIS:

The results are presented as mean±SD. P value <0.05 was considered statistically significant. Data distribution was checked with the Kolmogorov-Smirnov test. Within-group comparisons were made using ANOVA for repeated measurements. The unpaired t test or Mann-Whitney test were used to test the differences between the 2 study groups. For dependency analysis between 2 variables, Pearson’s r correlation coefficient was calculated. The statistical analysis was performed using Statistica (v. 10PL, StatSoft, Tulsa, OK, USA).

Results

Active energy expenditure increased significantly compared with baseline after completion of the 3-month physical training program in both KTx and CKD patients, (by 47%, p<0.001 and 20%, p=0.01, respectively). The time spent daily on physical activity followed the same pattern of changes (129±83 vs. 194±142 and 81±56.7 vs. 124±57.3 min, respectively, p<0.001). Adipose tissue mass decreased significantly only in KTx recipients (from 40.8±1.6 to 38.5±10.3 kg, p=0.01).

Serum leptin decreased significantly in both KTx and CKD patients (from 11.5±7.0 to 10.0±5.6, p=0.03 and from 14.1±8.3 to 12.2±6.1 ng/mL, p=0.01, respectively). Serum adiponectin increased in KTx patients (from 1900±953 to 2015±1133 ng/L, p=0.004) but not in CKD patients (1881±909 and 1905±925 ng/L, respectively).

Adiponectin expressed per body fat mass (ATM) increased significantly after 3 months of physical activity only in the KTx group (from 484.6±185.3 to 548.6±234.3 ng/lxkg, respectively, p=0.002). A significant decrease of leptin/ATM after 3 months of training was observed only in the KTx group (0.36±0.3 to 0.34±0.3 ng/lxkg, p=0.022). The changes in adiponectin/ATM and leptin/ATM in the CKD group were not significant (p=0.10). These results are shown in Table 2.

The percentage changes of active energy expenditure, physical activity, serum adiponectin, serum leptin, and adipose tissue mass are presented in Figure 1.

Serum CRP decreased in both groups – from 15.1±5.2 to 14.0±5.6 mg/L (p=0.01) in KTx patients and from 16.5±3.9 to 15.4±4.3 mg/L (p=0.05) in CKD patients). A significant positive linear correlation between serum leptin and CRP in KTx group was found at baseline (r=0.59, p=0.007) and after 3 months of exercise training (r=0.72, p=0.0004, respectively). No significant correlations between serum leptin and CRP were found in the CKD group.

In the KTx group, we also found a significant negative correlation between CRP and adiponectin at baseline and at 3 months (r=−0.69, p=0.001; r=−0.77, p=0.001).

NT-proBNP at 3 months did not significantly change in either group (544±294 vs. 537±317 and 514±170 pg/mL vs. 512±161 pg/mL, respectively).

Discussion

The main finding of the study was the observation that the significant increase in physical activity in both KTx and CKD patients led to a simultaneous decrease of adipose tissue mass and increase of serum adiponectin concentration.

Although adiponectin is secreted by adipose cells, its concentration is inversely related to BMI [17], and this was also seen in our study. Our study showed that the changes in adiposity and serum adiponectin were inversely correlated in KTx patients. However, Boudou et al. found that serum adiponectin concentration remained unchanged despite a reduced adipose tissue mass and increased insulin sensitivity after 8 weeks of physical exercises in 16 middle-aged men with type 2 diabetes and without significant impairment of kidney function [18].

It has been recently shown that serum adiponectin levels are higher in patients with CKD and in patients receiving renal replacement therapy including hemodialysis and peritoneal dialysis [19], most probably due to reduced clearance of adiponectin by the kidneys [19,20]. We observed higher concentrations of adiponectin after the training program, both in TX and CKD patients.

Taherimahmoudi et al. found that the level of adiponectin was higher in kidney transplant candidates than in healthy subjects, and remained increased even after kidney transplantation [21]. In this context, it would be worth analyzing to what extent our findings were the result of increased physical activity, and to what extent they were caused by the kidney function impairment itself.

It is noteworthy that the higher beneficial effect in the group of kidney transplant patients may be related with the difference in psychological status between the 2 groups.

In CKD patients, there was decreased leptin concentration at the end of the study, despite the fact that adipose tissue mass did not change in these patients. Recent studies reported that leptin level is correlated with high CRP level [22,23]. At the end of our study, CRP levels in both groups were significantly lower than at baseline, which might be influenced by the significant reduction of adipose tissue mass in both groups.

Scotece et al. [24] showed that despite the important role played by leptin in the initiation of inflammation processes, the use of agents that inhibit inflammatory cytokines did not affect its serum concentration.

We showed a significant reduction of serum C-reactive protein in both groups, which may be indirect evidence of a potentially beneficial effect of physical activity on chronic inflammation in patients with CKD and in KTx patients. It is important to mention that CRP can increase immediately as a response to exercise, but in our study the long-term effect was assessed [25]. However, CKD patients are a sedentary population with physical activity levels that are significantly lower than recommended by national guidelines [26,27]. Physical capacity is markedly lower in CKD stages 3–5 compared to healthy subjects, and higher CRP directly after exercise might not occur or might be lower than would be expected due to the much less strenuous exercise performed [28–30]. Moreover, in our study, we did not measure serum CRP immediately after exercise [26].

NTpro-BNP has been recognized as a serum marker of overhydration. Booth et al. showed that NT-pro BNP expression is modulated not only by volume overload, but is also affected by malnutrition [31]. It was demonstrated that high fluid status and high fat tissue index were associated with impaired upper and lower extremity muscle endurance in CKD patients [32].

In our study, NTpro-BNP concentration was unchanged despite the changes in ATM and adipokines in CKD and KTx patients. Our results contrast with some previous studies. Neeland et al. [33] showed that higher concentrations of BNP were independently associated with reduced visceral and hepatic adipose tissue mass and increased adipose tissue mass of the lower body parts, suggesting a direct relationship between adipose tissue mass and its hormonal activity and the production of the natriuretic peptides.

Our patients were encouraged to undertake physical activity through short text message reminders. Sarabi et al. confirmed the role of mobile technologies in patient compliance [34], but it has not been confirmed by other studies [35].

Our study has several limitations. We did not measure interleukin-6, which is directly secreted from visceral fat to the portal circulation and reaches the liver in high concentrations [36]. Another important issue is the lack of a thoroughly conducted assessment of the effect of medicines taken by the patients during the study, especially renin-angiotensin-aldosterone system blocking drugs, but it is noteworthy that the dose of all the concomitant drugs was unchanged for at least 3 months before and, more importantly, during the study. Another limitation of our study is that much of the biologically active adiponectin molecule is thought to arise from high molecular weight forms, and total levels may be only be a surrogate indicator of this [37].

Conclusions

In summary, the beneficial impact of physical activity on adipokines in both groups was demonstrated, with more pronounced effect in patients after kidney transplantation. This physical activity program benefit KTx recipients.

References

1. Zelle DM, Klaassen G, van Adrichem E, Physical inactivity: A risk factor and target for intervention in renal care: Nat Rev Nephrol, 2017; 13; 152-68, pmid: 28138130

2. Zelle DM, Corpeleijn E, Stolk RP, Low physical activity and risk of cardiovascular and all-cause mortality in renal transplant recipients: Clin J Am Soc Nephrol, 2011; 6; 898-905, pmid: 21372213

3. Ojo AO, Cardiovascular complications after renal transplantation and their prevention: Transplant, 2006; 82; 603-11

4. Ali A, Macphee I, Kaski JC, Banerjee D, Cardiac and vascular changes with kidney transplantation: Indian J Nephrol, 2016; 26; 1-9, pmid: 26937071

5. Bellizzi V, Cupisti A, Capitanini A, Physical activity and renal transplantation: Kidney Blood Press Res, 2014; 39; 212-19, pmid: 25118089

6. Romano G, Lorenzon E, Montanaro D, Effects of exercise in renal transplant recipients: World J Transplantation, 2012; 2; 46-50

7. Takahashi A, Hu SL, Bostom A, Physical activity in kidney transplant recipients: A review: Am J Kidney Dis, 2018; 72; 433-43, pmid: 29482935

8. Ahima RS, Adipose tissue as an endocrine organ: Obesity (Silver Spring), 2006; 14(Suppl 5); 242-49

9. Stern JH, Rutkowski JM, Scherer PE, Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk: Cell Metab, 2016; 23; 770-84, pmid: 27166942

10. Harris RBS, Direct and indirect effects of leptin on adipocyte metabolism: Biochim Biophys Acta, 2014; 1842; 414-23, pmid: 23685313

11. Wolf G, Obesity and the kidney: Contrib Nephrol Basel, 2006; 151; 175-83

12. Shah SH, Newby LK, C-reactive protein: A novel marker of cardiovascular risk: Cardiol Rev, 2003; 11; 169-79, pmid: 12852794

13. Fedewa MV, Hathaway ED, Ward-Ritacco CL, Effect of exercise training on C reactive protein: A systematic review and meta-analysis of randomised and non-randomised controlled trials: Br J Sports Med, 2017; 51; 670-76, pmid: 27445361

14. Kasapis C, Thompson PD, The effects of physical activity on serum C-reactive protein and inflammatory markers a systematic review: J Am Coll Cardiol, 2005; 45; 1563-69, pmid: 15893167

15. Niizuma S, Iwanaga Y, Yahata T, Miyazaki S, Renocardiovascular biomarkers: From the perspective of managing chronic kidney disease and cardiovascular disease: Front Cardiovasc Med, 2017; 4; 10, pmid: 28321399

16. Bellizzi V, Cupisti A, Capitanini A, Physical activity and renal transplantation: Kidney Blood Press Res, 2014; 39; 212-19, pmid: 25118089

17. Chitalia N, Raja RB, Bhandara T, Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation: J Nephrol, 2010; 23; 77-84, pmid: 20091490

18. Boudou P, Sobngwi R, Mauvais-Jarvis F, Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men: Eur J Endocrinol, 2003; 149; 421-24, pmid: 14585088

19. Heidari M, Nasri P, Nasri H, Adiponectin and chronic kidney disease; A review on recent findings: J Nephropharmacol, 2015; 4; 63-68, pmid: 28197480

20. Martinez Cantarin MP, Waldman SA, Doria C, The adipose tissue production of adiponectin is increased in end-stage renal disease: Kidney Int, 2013; 83; 487-94, pmid: 23283133

21. Taherimahmoudi M, Ahmadi H, Mehrsai A, Pourmand G, Plasma adiponectin concentration and insulin resistance: Role of successful kidney transplantation: Transplant Proc, 2010; 42; 797-800, pmid: 20430175

22. Shankar A, Syamala S, Xiao J, Muntner P, Relationship between plasma leptin level and chronic kidney disease: Int J Nephrol, 2012; 2012 269532

23. Shamsuzzaman ASM, Winnicki M, Wolk R, Independent association between plasma leptin and C-reactive protein in healthy humans: Circulation, 2004; 109; 2181-85, pmid: 15117839

24. Scotece M, Conde J, López V, Adiponectin and leptin: New targets in inflammation: Basic Clin Pharmacol Toxicol, 2014; 114; 97-102, pmid: 23834523

25. Nunes RA, Araújo F, Correia GF, High-sensitivity C-reactive protein levels and treadmill exercise test responses in men and women without overt heart disease: Exp Clin Cardiol, 2013; 18; 124-28, pmid: 23940437

26. Dungey M, Hull KL, Smith AC, Inflammatory factors and exercise in chronic kidney disease: Int J Endocrinol, 2013; 2013 569831

27. Akber A, Portale AA, Johansen KL, Pedometer-assessed physical activity in children and young adults with CKD: Clinical J Am Soc Nephrol, 2012; 7; 720-26, pmid: 22422539

28. Johansen KL, Painter P, Exercise in individuals with CKD: Am J Kidney Dis, 2011; 59; 126-34, pmid: 22113127

29. Brodin E, Ljungman S, Sunnerhagen KS, Rising from a chair: A simple screening test for physical function in predialysis patients: Scandinavian J Urol Nephrol, 2008; 42; 293-300

30. Padilla J, Krasnoff J, Silva M, Physical functioning in patients with chronic kidney disease: Am J Nephrol, 2008; 4; 550-59

31. Booth J, Pinney J, Davenport A, N-terminal proBNP – marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?: Clin J Am Soc Nephrol, 2010; 5; 1036-40, pmid: 20507952

32. Hsiao SM, Tsai YC, Chen HM, Association of fluid status and body composition with physical function in patients with chronic kidney disease: PLoS One, 2016; 11(10); e0165400, pmid: 27798648

33. Neeland IJ, Winders BR, Ayers CR, Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile: J Am Coll Cardiol, 2013; 62; 752-60, pmid: 23602771

34. Ershad Sarabi R, Sadoughi F, Jamshidi Orak R, Bahaadinbeigy K, The effectiveness of mobile phone text messaging in improving medication adherence for patients with chronic diseases: A systematic review: Iran Red Crescent Med J, 2016; 18; 251-83

35. Heino MTJ, Knittle K, Haukkala A, Simple and rationale-providing SMS reminders to promote accelerometer use: A within-trial randomised trial comparing persuasive messages: BMC Public Health, 2018; 18; 1352, pmid: 30526616

36. Mirza MS, Obesity, visceral fat, and NAFLD: Querying the role of adipokines in the progression of nonalcoholic fatty liver disease: ISRN Gastroenterol, 2011

37. Zhu N, Pankow JS, Ballantyne CM, High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study: J Clin Endocrinol Metab, 2010; 95; 5097-104, pmid: 20719834

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358